Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding Curis Inc changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CRIS: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders6861−7
Shares31.5M28.7M−2.80M (−8.9%)
Value$17.3M$17.1M−$218.0K (−1.3%)

New holders (3)

Institutions that held Curis Inc at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CRIS in Q1 2023
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP37,076$22.0K0.00%
Victory Capital Management Inc10,152$6.05K0.00%
TD Waterhouse Canada Inc.1,000$5720.00%

Sold out (10)

Institutions that held Curis Inc at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of CRIS in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Ally Bridge Group (NY) LLC827,397$455.1K
Sabby Management, LLC225,886$124.2K
Acadian Asset Management LLC127,395$70.0K
Virtu Financial LLC92,989$51.0K
Ergoteles LLC74,979$41.2K
HRT Financial LP53,921$29.0K
Two Sigma Securities, LLC24,356$13.4K
Simplex Trading, LLC24,518$13.0K
Signaturefd, LLC1,500$825
IFP Advisors, Inc100–